Stay updated on Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Sign up to get notified when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.

Latest updates to the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: Melanoma and MedlinePlus Genetics to the Related Topics section; no deletions observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check14 days agoChange DetectedRevision: v3.4.2 is shown as the system revision label, and the government funding operating-status notice has been removed. There are no changes to trial content, eligibility criteria, locations, or study outcomes.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a funding/status notice and a version revision (v3.4.1). Removed Melanoma and related topics (MedlinePlus Genetics) from the page.SummaryDifference0.6%

- Check28 days agoChange DetectedThe page now displays a glossary option and adds new metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). It also removes the older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Melanoma as a topic label, added related topic 'MedlinePlus Genetics', and updated page revision from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedRemoved the Melanoma topic and the MedlinePlus Genetics related topic from the Study Details page.SummaryDifference0.2%

Stay in the know with updates to Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadjuvant PD-1 Blockade in Stage IIB/C Melanoma Clinical Trial page.